Click for best price
Gene Therapies for Cancer Treatment Market Size, Share 2022
In the medicine field, gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
This report contains market size and forecasts of Gene Therapies for Cancer Treatment in Global, including the following market information:
Global Gene Therapies for Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gene Therapies for Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Somatic Cell Gene Therapy (SCGT) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gene Therapies for Cancer Treatment include Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics and Ziopharm Oncology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Therapies for Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapies for Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gene Therapies for Cancer Treatment Market Segment Percentages, by Type, 2021 (%)
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Global Gene Therapies for Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gene Therapies for Cancer Treatment Market Segment Percentages, by Application, 2021 (%)
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
Global Gene Therapies for Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gene Therapies for Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapies for Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gene Therapies for Cancer Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio
| Report Attributes |
Report Details |
| Report Title |
Gene Therapies for Cancer Treatment Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene Therapies for Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapies for Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapies for Cancer Treatment Overall Market Size
2.1 Global Gene Therapies for Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Gene Therapies for Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapies for Cancer Treatment Players in Global Market
3.2 Top Global Gene Therapies for Cancer Treatment Companies Ranked by Revenue
3.3 Global Gene Therapies for Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapies for Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene Therapies for Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapies for Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapies for Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapies for Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Gene Therapies for Cancer Treatment Market Size Markets, 2021 & 2028
4.1.2 Somatic Cell Gene Therapy (SCGT)
4.1.3 Germline Gene Therapy (GGT)
4.2 By Type - Global Gene Therapies for Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Gene Therapies for Cancer Treatment Revenue, 2017-2022
4.2.2 By Type - Global Gene Therapies for Cancer Treatment Revenue, 2023-2028
4.2.3 By Type - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapies for Cancer Treatment Market Size, 2021 & 2028
5.1.2 Cancer Research Centers
5.1.3 Diagnostic Laboratories
5.1.4 Cancer Hospitals
5.1.5 Others
5.2 By Application - Global Gene Therapies for Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Gene Therapies for Cancer Treatment Revenue, 2017-2022
5.2.2 By Application - Global Gene Therapies for Cancer Treatment Revenue, 2023-2028
5.2.3 By Application - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Gene Therapies for Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Gene Therapies for Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Gene Therapies for Cancer Treatment Revenue, 2017-2022
6.2.2 By Region - Global Gene Therapies for Cancer Treatment Revenue, 2023-2028
6.2.3 By Region - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Gene Therapies for Cancer Treatment Revenue, 2017-2028
6.3.2 US Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.3.3 Canada Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.3.4 Mexico Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Gene Therapies for Cancer Treatment Revenue, 2017-2028
6.4.2 Germany Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.3 France Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.4 U.K. Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.5 Italy Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.6 Russia Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.8 Benelux Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Gene Therapies for Cancer Treatment Revenue, 2017-2028
6.5.2 China Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.5.3 Japan Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.5.4 South Korea Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.5.6 India Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Gene Therapies for Cancer Treatment Revenue, 2017-2028
6.6.2 Brazil Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.6.3 Argentina Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapies for Cancer Treatment Revenue, 2017-2028
6.7.2 Turkey Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.7.3 Israel Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.7.5 UAE Gene Therapies for Cancer Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Takara Bio
7.1.1 Takara Bio Corporate Summary
7.1.2 Takara Bio Business Overview
7.1.3 Takara Bio Gene Therapies for Cancer Treatment Major Product Offerings
7.1.4 Takara Bio Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.1.5 Takara Bio Key News
7.2 Tocagen
7.2.1 Tocagen Corporate Summary
7.2.2 Tocagen Business Overview
7.2.3 Tocagen Gene Therapies for Cancer Treatment Major Product Offerings
7.2.4 Tocagen Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.2.5 Tocagen Key News
7.3 VBL Therapeutics
7.3.1 VBL Therapeutics Corporate Summary
7.3.2 VBL Therapeutics Business Overview
7.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Major Product Offerings
7.3.4 VBL Therapeutics Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.3.5 VBL Therapeutics Key News
7.4 Cold Genesys
7.4.1 Cold Genesys Corporate Summary
7.4.2 Cold Genesys Business Overview
7.4.3 Cold Genesys Gene Therapies for Cancer Treatment Major Product Offerings
7.4.4 Cold Genesys Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.4.5 Cold Genesys Key News
7.5 Genprex
7.5.1 Genprex Corporate Summary
7.5.2 Genprex Business Overview
7.5.3 Genprex Gene Therapies for Cancer Treatment Major Product Offerings
7.5.4 Genprex Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.5.5 Genprex Key News
7.6 Momotaro-Gene
7.6.1 Momotaro-Gene Corporate Summary
7.6.2 Momotaro-Gene Business Overview
7.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Major Product Offerings
7.6.4 Momotaro-Gene Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.6.5 Momotaro-Gene Key News
7.7 MultiVir
7.7.1 MultiVir Corporate Summary
7.7.2 MultiVir Business Overview
7.7.3 MultiVir Gene Therapies for Cancer Treatment Major Product Offerings
7.7.4 MultiVir Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.7.5 MultiVir Key News
7.8 SynerGene Therapeutics
7.8.1 SynerGene Therapeutics Corporate Summary
7.8.2 SynerGene Therapeutics Business Overview
7.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Major Product Offerings
7.8.4 SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.8.5 SynerGene Therapeutics Key News
7.9 Ziopharm Oncology
7.9.1 Ziopharm Oncology Corporate Summary
7.9.2 Ziopharm Oncology Business Overview
7.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Major Product Offerings
7.9.4 Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.9.5 Ziopharm Oncology Key News
7.10 Anchiano Therapeutics
7.10.1 Anchiano Therapeutics Corporate Summary
7.10.2 Anchiano Therapeutics Business Overview
7.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Major Product Offerings
7.10.4 Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.10.5 Anchiano Therapeutics Key News
7.11 Celgene
7.11.1 Celgene Corporate Summary
7.11.2 Celgene Business Overview
7.11.3 Celgene Gene Therapies for Cancer Treatment Major Product Offerings
7.11.4 Celgene Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.11.5 Celgene Key News
7.12 Celsion
7.12.1 Celsion Corporate Summary
7.12.2 Celsion Business Overview
7.12.3 Celsion Gene Therapies for Cancer Treatment Major Product Offerings
7.12.4 Celsion Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.12.5 Celsion Key News
7.13 Bluebird Bio
7.13.1 Bluebird Bio Corporate Summary
7.13.2 Bluebird Bio Business Overview
7.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Major Product Offerings
7.13.4 Bluebird Bio Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.13.5 Bluebird Bio Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene Therapies for Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Gene Therapies for Cancer Treatment Market Drivers in Global Market
Table 3. Gene Therapies for Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Gene Therapies for Cancer Treatment in Global Market
Table 5. Top Gene Therapies for Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gene Therapies for Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gene Therapies for Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gene Therapies for Cancer Treatment Product Type
Table 9. List of Global Tier 1 Gene Therapies for Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapies for Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gene Therapies for Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gene Therapies for Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gene Therapies for Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gene Therapies for Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gene Therapies for Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gene Therapies for Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Takara Bio Corporate Summary
Table 31. Takara Bio Gene Therapies for Cancer Treatment Product Offerings
Table 32. Takara Bio Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Tocagen Corporate Summary
Table 34. Tocagen Gene Therapies for Cancer Treatment Product Offerings
Table 35. Tocagen Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. VBL Therapeutics Corporate Summary
Table 37. VBL Therapeutics Gene Therapies for Cancer Treatment Product Offerings
Table 38. VBL Therapeutics Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Cold Genesys Corporate Summary
Table 40. Cold Genesys Gene Therapies for Cancer Treatment Product Offerings
Table 41. Cold Genesys Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Genprex Corporate Summary
Table 43. Genprex Gene Therapies for Cancer Treatment Product Offerings
Table 44. Genprex Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Momotaro-Gene Corporate Summary
Table 46. Momotaro-Gene Gene Therapies for Cancer Treatment Product Offerings
Table 47. Momotaro-Gene Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 48. MultiVir Corporate Summary
Table 49. MultiVir Gene Therapies for Cancer Treatment Product Offerings
Table 50. MultiVir Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 51. SynerGene Therapeutics Corporate Summary
Table 52. SynerGene Therapeutics Gene Therapies for Cancer Treatment Product Offerings
Table 53. SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Ziopharm Oncology Corporate Summary
Table 55. Ziopharm Oncology Gene Therapies for Cancer Treatment Product Offerings
Table 56. Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Anchiano Therapeutics Corporate Summary
Table 58. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product Offerings
Table 59. Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Celgene Corporate Summary
Table 61. Celgene Gene Therapies for Cancer Treatment Product Offerings
Table 62. Celgene Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Celsion Corporate Summary
Table 64. Celsion Gene Therapies for Cancer Treatment Product Offerings
Table 65. Celsion Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Bluebird Bio Corporate Summary
Table 67. Bluebird Bio Gene Therapies for Cancer Treatment Product Offerings
Table 68. Bluebird Bio Gene Therapies for Cancer Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Gene Therapies for Cancer Treatment Segment by Type in 2021
Figure 2. Gene Therapies for Cancer Treatment Segment by Application in 2021
Figure 3. Global Gene Therapies for Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gene Therapies for Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gene Therapies for Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Takara Bio Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Tocagen Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. VBL Therapeutics Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cold Genesys Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Genprex Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Momotaro-Gene Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. MultiVir Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Celgene Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Celsion Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Bluebird Bio Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
